Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation
Status:
Unknown status
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
1. The purpose of this study is to determine the efficacy of ramosetron for the prevention
of emesis and the control of nausea and vomiting despite of the prophylactic antiemetic
treatment during hematopoietic stem cell transplantation
2. The study hypothesis is that ramosetron is effective for the prevention of emesis and
control of emesis and/or vomiting that develop after the prophylactic antiemetic therapy
in the setting of hematopoietic stem cell transplantation